Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-15-174666
Filing Date
2015-05-06
Accepted
2015-05-06 16:36:59
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10Q d913153d10q.htm 10-Q 497084
2 EX-31.1 d913153dex311.htm EX-31.1 7434
3 EX-31.2 d913153dex312.htm EX-31.2 7495
4 EX-32.1 d913153dex321.htm EX-32.1 4922
  Complete submission text file 0001193125-15-174666.txt   4456357

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT immu-20150331.xml EX-101.INS 547178
6 XBRL TAXONOMY EXTENSION SCHEMA immu-20150331.xsd EX-101.SCH 41718
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE immu-20150331_cal.xml EX-101.CAL 58887
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE immu-20150331_def.xml EX-101.DEF 132102
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE immu-20150331_lab.xml EX-101.LAB 359643
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE immu-20150331_pre.xml EX-101.PRE 245736
Mailing Address 300 AMERICAN ROAD MORRIS PLAINS NJ 07950
Business Address 300 AMERICAN RD MORRIS PLAINS NJ 07950 9736058200
IMMUNOMEDICS INC (Filer) CIK: 0000722830 (see all company filings)

EIN.: 611009366 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-12104 | Film No.: 15837504
SIC: 2835 In Vitro & In Vivo Diagnostic Substances